Search research articles
Contact Us
Filters
Showing results (851-860 of 1,116) with videos related to
Page
of 112
Sort By:
Journal of the American College of Cardiology
|
March 15, 1997
Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators
A Barbagelata, R M Califf, E B Sgarbossa, et al.
Neurology
|
February 1, 1990
Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data
C G Goetz, C M Tanner, R D Penn, et al.
Nature Communications
|
April 25, 2019
A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors
Rajiv S Jumani, Muhammad M Hasan, Erin E Stebbins, et al.
Toxicology Letters
|
April 8, 2024
The fentanyl-specific antibody FenAb024 can shield against carfentanil effects
Katharina Urban, Anastasia Gkeka, Monica Chandra, et al.
European Heart Journal
|
April 26, 2016
Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease
Ralph A H Stewart, Lars Wallentin, Jocelyne Benatar, et al.
Molecular Medicine (Cambridge, Mass.)
|
June 13, 2015
A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo
Davorka Messmer, Kymmy Lorrain, Karin Stebbins, et al.
European Journal of Pharmacology
|
May 10, 2017
In vitro and in vivo pharmacology of NXT629, a novel and selective PPARα antagonist
Karin J Stebbins, Alex R Broadhead, Geraldine Cabrera, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 11, 2009
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease
Marian L Evatt, K Ray Chaudhuri, Kelvin L Chou, et al.
European Journal of Pharmacology
|
May 8, 2010
Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation
Karin J Stebbins, Alex R Broadhead, Lucia D Correa, et al.
Journal of Medicinal Chemistry
|
June 27, 2009
Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins
Jun Wei, Shinichi Kitada, Michele F Rega, et al.
Page
of 112
Search research articles
Search
Showing results (851-860 of 1,116) with videos related to
Sort By:
Page
of 112
Journal of the American College of Cardiology
|
March 15, 1997
Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators
A Barbagelata, R M Califf, E B Sgarbossa, et al.
Neurology
|
February 1, 1990
Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data
C G Goetz, C M Tanner, R D Penn, et al.
Nature Communications
|
April 25, 2019
A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors
Rajiv S Jumani, Muhammad M Hasan, Erin E Stebbins, et al.
Toxicology Letters
|
April 8, 2024
The fentanyl-specific antibody FenAb024 can shield against carfentanil effects
Katharina Urban, Anastasia Gkeka, Monica Chandra, et al.
European Heart Journal
|
April 26, 2016
Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease
Ralph A H Stewart, Lars Wallentin, Jocelyne Benatar, et al.
Molecular Medicine (Cambridge, Mass.)
|
June 13, 2015
A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo
Davorka Messmer, Kymmy Lorrain, Karin Stebbins, et al.
European Journal of Pharmacology
|
May 10, 2017
In vitro and in vivo pharmacology of NXT629, a novel and selective PPARα antagonist
Karin J Stebbins, Alex R Broadhead, Geraldine Cabrera, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 11, 2009
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease
Marian L Evatt, K Ray Chaudhuri, Kelvin L Chou, et al.
European Journal of Pharmacology
|
May 8, 2010
Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation
Karin J Stebbins, Alex R Broadhead, Lucia D Correa, et al.
Journal of Medicinal Chemistry
|
June 27, 2009
Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins
Jun Wei, Shinichi Kitada, Michele F Rega, et al.
Page
of 112